Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

42.9%

3 terminated/withdrawn out of 7 trials

Success Rate

40.0%

-46.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

2(28.6%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 3(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03646955Not ApplicableRecruiting

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Role: collaborator

NCT01417676Not ApplicableCompleted

DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study

Role: collaborator

NCT00892814Not ApplicableActive Not Recruiting

Partial Breast Versus Whole Breast Irradiation in Elderly Women Operated on for Early Breast Cancer

Role: collaborator

NCT02025231Phase 1Terminated

Image Guided Reirradiation of High-grade Glioma

Role: collaborator

NCT01025518Not ApplicableCompleted

DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following Radiotherapy in Head and Neck Cancer Patients

Role: collaborator

NCT01507467Phase 3Terminated

IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck

Role: collaborator

NCT01233544Phase 3Terminated

Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases

Role: collaborator

All 7 trials loaded